Real-world effectiveness of a single dose of mpox vaccine in males
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The recent global outbreak of the monkeypox (mpox) virus in humans was declared a public health emergency by the World Health Organization in July 2022. The smallpox and mpox vaccine (JYNNEOS; Modified Vaccinia Ankara-Bavarian Nordic; MVA-BN), provided as a two-dose regimen, is currently the primary vaccine utilized against mpox. However, the efficacy of MVA-BN against mpox has never been demonstrated in clinical trials to date. Due to the limited supply of vaccines, the World Health Organization has recommended prioritizing the vaccination of high-risk groups. We evaluated the real-world effectiveness of a single, subcutaneous dose of MVA-BN in this observational, retrospective cohort study, which included the analysis of electronic health records of all members of Clalit Health Services eligible for the vaccine on 31 July 2022. We used a Cox proportional hazards regression model with time-dependent covariates to estimate the association between vaccination and mpox while adjusting for sociodemographic and clinical risk factors. In an analysis of 2,054 male individuals who met vaccine eligibility criteria, 1,037 (50%) were vaccinated during the study recruitment period and completed at least 90 d of follow-up. During the study period, 5 and 16 infections were confirmed in vaccinated and unvaccinated individuals, respectively. The adjusted vaccine effectiveness was estimated at 86% (95% confidence interval, 59–95%). Our results suggest that a single dose of subcutaneous MVA-BN in this high-risk cohort is associated with a significantly lower risk of MPXV infection. Effectiveness of one subcutaneous dose of MVA-BN, the smallpox and mpox vaccine, was estimated to be 86% in a cohort of vaccine-eligible males in Israel, supporting its use to curtail the outbreak of mpox virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Purposeful selection of variables in logistic regression
Bursac, Z., Gauss, C. H., Williams, D. K., & Hosmer, D. W. (2008) · Source Code for Biology and Medicine · doi:10.1186/1751-0473-3-17 · Cited by 4,035
Cited by
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States
Deputy, N. P., Deckert, J., Chard, A. N., Sandberg, N., Moulia, D. L., Barkley, E., Dalton, A. F., Sweet, C., Cohn, A. C., Little, D. R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2215201 · Cited by 305
Metadata
- Authors
- Wolff Sagy, Y., Zucker, R., Hammerman, A., Markovits, H., Arieh, N. G., Abu Ahmad, W., Battat, E., Ramot, N., Carmeli, G., Mark-Amir, A., Wagner-Kolasko, G., Duskin-Bitan, H., Yaron, S., Peretz, A., Arbel, R., Lavie, G., & Netzer, D.
- Venue
- Nature Medicine
- Published
- 2023-01-31
- Volume
- 29
- Issue
- 3
- Pages
- 748-752
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4318695202
- Cited by
- 195
- References
- 1
- FWCI
- 23.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real-world effectiveness of a single dose of mpox vaccine in males. https://app.cochat.ai/papers/10.1038/s41591-023-02229-3
- The paper
- Wolff Sagy, Y., Zucker, R., Hammerman, A., Markovits, H., Arieh, N. G., Abu Ahmad, W., Battat, E., Ramot, N., Carmeli, G., Mark-Amir, A., Wagner-Kolasko, G., Duskin-Bitan, H., Yaron, S., Peretz, A., Arbel, R., Lavie, G., & Netzer, D. (2023). Real-world effectiveness of a single dose of mpox vaccine in males. Nature Medicine. https://doi.org/10.1038/s41591-023-02229-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.